Mucormycosis

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

  A post-marketing surveillance study of Cresemba (isavuconazole) in Korea has completed, evaluating safety and usage in patients with aspergi…

• CLINICAL_TRIALS trial_result · 2026-03-05
  Clinical Trial Update: Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

  A single-center comparative analysis from China assessing how the burden of mucormycosis evolves in patients with hematologic malignancies d…

• CLINICAL_TRIALS trial_result · 2026-03-04
  Clinical Trial Update: Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment [Phase 2]

  A Phase 2 pilot trial of high-dose liposomal amphotericin B for initial treatment of mucormycosis has completed.

• CLINICAL_TRIALS trial_result · 2025-12-09
  Clinical Trial Update: A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.

  This completed trial evaluated whether Paxlovid (nirmatrelvir/ritonavir) influenced healthcare utilization in people with pre-existing condi…

• CLINICAL_TRIALS trial_result · 2024-02-20
  Clinical Trial Update: World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt [Phase 1, Phase 2]

  A completed Phase 1/2 clinical trial update focusing on post-COVID-19 rhinocerebral mucormycosis in Egypt.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2011-10-06
  Clinical Trial Update: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study [Phase 2]

  Phase 2 trial update for Deferasirox-AmBisome therapy in mucormycosis has completed with results posted in 2011.